Infection Control Today Magazine - healthcare-acquired infections (HAIs), hospital infections, infection prevention and control, healthcare epidemiology, aseptic technique, environmental hygiene, hand hygiene, disinfection and sterilization, outbreak investigation, surveillance

FEATURES

SSIs in Ambulatory Surgery

In an analysis that included nearly 300,000 patients from eight states who underwent ambulatory surgery, researchers found that the rates of surgical ...read more

Hand Sanitizer Missing in Some Hospitals

Approximately 1 in 5 U.S. healthcare facilities don't make alcohol-based hand sanitizer available at every point of care, missing a critical ...read more

Infection Prevention Compliance

Infection Control Today invited infection preventionists to tell us about their experiences with boosting and maintaining compliance with infection ...read more

PPE Utilization in a Pandemic

This report explores the utilization of personal protective equipment and respiratory protection within a pandemic scenario and addresses key issues ...read more

Biocides and Sporicidal Disinfectants

This Pulse provides a quick summary of some of the ideas and perspectives coming out of the 2013 Spring Conference of the Society of Healthcare ...read more

Latest Headlines

Datascope Announces Safeguard Hemostasis Device

MONTVALE, N.J. -- Datascope Corp. announces the worldwide launch of Safeguard, an innovative, inflatable pressure-dressing designed to maintain hemostasis after manual compression for arterial catheterization procedures. Safeguard will compete in an estimated $54 million ...More
December 8, 2003 Posted in News
How Harmful Are Additives and Preservatives in Childhood Vaccines? Review of Scientific Data May Allay Parental Concerns on Vaccine Safety, Says Expert

PHILADELPHIA -- After reviewing dozens of scientific studies, a leading vaccine expert concludes that preservatives, additives and other substances contained in vaccines pose very little risk to children receiving those vaccines. In addition to the primary ingredient that ...More
December 8, 2003 Posted in News
Trial of New Investigational AIDS Vaccine Begins in New York

NEW YORK -- The Aaron Diamond AIDS Research Center (ADARC), an affiliate of The Rockefeller University, and the International AIDS Vaccine Initiative (IAVI) announced today that they have begun a human trial of a new investigational vaccine to prevent HIV/AIDS. The trial is ...More
December 8, 2003 Posted in News
Bioject Announces National Institutes of Health Begins Human Ebola Vaccine Trial Utilizing Biojector 2000

BEDMINSTER, N.J. -- Bioject Medical Technologies Inc., a leading developer of needle-free drug delivery systems, announced today that the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of ...More
December 8, 2003 Posted in News
Ansell Introduces Powder-free and Latex-free Exam Glove with Superior Fit and Feel

RED BANK, N.J. -- Ansell Professional Healthcare introduces the Micro-Touch Affinity, powder-free and latex-free exam gloves that provide the protection, tactile sensitivity and comfort of latex gloves without the risk associated with latex allergies. Developed from ...More
December 8, 2003 Posted in News, Hand Hygiene, PPE & Standard Precautions
Immtech's DB289 Demonstrates Potent Anti-Malarial Results in Human Clinical Trial

VERNON HILLS, Ill. -- Immtech International, Inc. announces that the company's oral drug candidate, DB289, demonstrated potent anti-malarial activity in the human clinical trial conducted in Bangkok, Thailand. The results were presented at the Annual Meeting of the American ...More
December 8, 2003 Posted in News
Microscience to Work with the U.S. Naval Medical Research Center on New Oral Anthrax Vaccine

LONDON, England -- With bioterrorism remaining a high priority for government on both sides of the Atlantic, it is timely for the UK-based biotechnology company Microscience to announce that it has entered into a Cooperative Research and Development Agreement (CRADA) with ...More
December 8, 2003 Posted in News
Sterilox Technologies A-2000 Device Receives NSF Certification For Food Industry Use

RADNOR, Pa. -- Sterilox Technologies, Inc. announced today that its A-2000 generator has received C2 certification for food equipment by NSF International and has earned the ability to display the NSF Certification Mark on this device. This certification, granted to food ...More
December 8, 2003 Posted in News
ID Biomedical Reports Positive Laboratory-confirmed Influenza Results From FluINsure Vaccine

VANCOUVER -- ID Biomedical announced today that analysis of laboratory data from the Company's most recent influenza human challenge study of its non-live, intranasal FluINsure vaccine confirmed the efficacy of both the one- and two-dose vaccine regimens. The trial was a ...More
December 5, 2003 Posted in News
Aventis Completes Shipment of Approximately 43 Million Doses of Influenza Vaccine

SWIFTWATER, Pa. -- Aventis today announced the company has completed shipment of approximately 43 million doses of its influenza vaccine (Fluzone, Influenza Virus Vaccine) to customers for the 2003-4 influenza season. The company was the first manufacturer to ship influenza ...More
December 5, 2003 Posted in News